Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oncocyte Corporation - Common Stock (NQ:OCX)

3.200 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oncocyte Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
Via Benzinga
News headline image
Oncocyte Implements Cost Reduction Initiatives, Realigns Operations ↗
 
Via Benzinga
News headline image
Oncocyte Enters $2B Market With Transplant Rejection Monitoring Test ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 96 stocks hit new 52-week lows. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Expert Ratings for OncoCyte ↗
Within the last quarter, OncoCyte (NASDAQ:OCX) has observed the following analyst ratings: 
Via Benzinga
News headline image
Earnings Scheduled For May 11, 2022 ↗
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
News headline image
2 Stocks Under $2 Insiders Are Aggressively Buying ↗
Gold futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Talk Markets
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Good morning, investor! Let's get right into the biggest pre-market stock movers on Monday that traders will want to watch! 
Via InvestorPlace
News headline image
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket ↗
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Earnings Scheduled For March 10, 2022 ↗
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
News headline image
OncoCyte And 2 Other Stocks Under $1 Insiders Are Aggressively Buying ↗
The Dow Jones dropped by around 170 points on Wednesday following the release of Fed minutes. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Expert Ratings for OncoCyte ↗
  Over the past 3 months, 3 analysts have published their opinion on OncoCyte (NASDAQ:OCX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Oncocyte Reports That Its First-Of-Its-Kind DetermaCNI Blood Test That Tracks Cancer Treatment Progress Could Hit Market By 2023 ↗
Image by Nguyễn Hiệp on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
News headline image
OncoCyte: Q1 Earnings Insights ↗
OncoCyte (NASDAQ:OCX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings OncoCyte reported in-line EPS of... 
Via Benzinga
News headline image
Oncocyte Reports It's Ready To Enter The $3.6 Billion Transplant Diagnostics Market In First Half Of 2022 ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. The transplant diagnostics market encompasses blood tests,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
2 Stocks Under $2 Insiders Are Aggressively Buying ↗
Gold futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around... 
Via Benzinga
News headline image
4 Stocks Under $5 Insiders Are Aggressively Buying ↗
US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
The biggest pre-market stock movers for Thursday are ready and waiting so let's see what's moving the market this morning! 
Via InvestorPlace
News headline image
Oncocyte And Thermo Fisher Report Teaming Up To Bring Precision Medicine To Cancer Patients Worldwide ↗
Image provided by Thermo Fisher Scientific Inc. This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About OncoCyte ↗
OncoCyte (NASDAQ:OCX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2022 ↗
Upgrades Janney Montgomery Scott upgraded the previous rating for Enova International Inc (NYSE:ENVA) from Neutral to Buy. Enova International earned $1.61 in the fourth quarter,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.8% to $1.55 during Thursday's after-market session. The company's market cap stands at $92.4 million. As per the press release, Q4... 
Via Benzinga
News headline image
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.